Business Avita Medical outlines 2026 revenue target of $80M-$85M as reimbursement clarity supports multiproduct utilization
Business CoreCivic targets $2.5B revenue and up to $445M EBITDA in 2026 with expanded federal contracts
Business NorthWestern outlines $3.21B capital plan and 5% EPS growth target as merger and data center deals advance
Business Nabors Industries outlines 6%–8% normalized EBITDA growth for 2026 while expanding international rig count and reducing debt
Business Essential Properties outlines 2026 AFFO per share guidance growth up to 8% while capitalizing on resilient credit trends
Business Karyopharm signals $130M–$150M revenue target for 2026 with pivotal myelofibrosis data readout ahead